Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia
David Whiley
, Ella Trembizki, Cameron Buckley, Kevin Freeman, Robert W. Baird, Miles Beaman, Marcus Y. Chen, Basil Donovan, Ratan L. Kundu, Christopher K. Fairley, Rebecca Guy, Tiffany Hogan, John M. Kaldor, Mahdad Karimi, Athena Limnios, David G. Regan, Nathan Ryder, Jiunn-Yih Su, James Ward, and Monica M. Lahra
Author affiliations: Pathology Queensland Central Laboratory, Brisbane, Queensland, Australia (D. Whiley); The University of Queensland, Brisbane (D. Whiley, E. Trembizki, C. Buckley); Royal Darwin Hospital, Darwin, Northern Territory, Australia (K. Freeman, R.W. Baird); University of Western Australia, Nedlands, Western Australia, Australia (M. Beaman); University of Notre Dame Australia, Fremantle, Western Australia, Australia (M. Beaman); Western Diagnostic Pathology, Perth, Western Australia, Australia (M. Beaman, M. Karimi); Alfred Health, Carlton, Victoria, Australia (M. Chen, C.K. Fairley); Central Clinical School, Monash University, Melbourne, Victoria, Australia (M. Chen, C.K. Fairley); Sydney Hospital, Sydney, New South Wales, Australia (B. Donovan); University of New South Wales, Sydney (B. Donovan, R. Guy, J.M. Kaldor, D.G. Regan, N. Ryder, M.M. Lahra); Prince of Wales Hospital, Sydney (R.L. Kundu, T. Hogan, A. Limnios, M.M. Lahra); School of Medical Sciences, Hunter New England Local Health District, Sydney (N. Ryder); Menzies School of Health Research and Charles Darwin University, Darwin (J.-Y. Su); South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia (J. Ward); Flinders University, Adelaide (J. Ward)
Main Article
Table 3
Summary of mosaicPBP2-PCR–positive Neisseria gonorrhoeae samples from the Northern Territory of Australia*
Patient no. |
Sex |
Age group, y |
Aborigine |
Sample source |
Date of collection |
NG-MAST genotype |
1
|
M
|
51–55
|
No
|
Urine
|
January 2014
|
10038
|
2
|
M
|
21–25
|
No
|
Urine
|
March 2014
|
2212
|
3
|
F
|
26–30
|
Yes
|
Urine |
April 2014 |
2212 |
Pharyngeal swab
|
May 2014
|
2212
|
4
|
M
|
26–30
|
Yes
|
Urine
|
April 2014
|
2212
|
5
|
F
|
<20
|
Yes
|
Urine
|
May 2014
|
2212
|
6
|
M
|
21–25
|
No
|
Urine
|
February 2014
|
5622
|
7
|
M
|
56–60
|
No
|
Urine
|
December 2014
|
5622
|
8
|
M
|
21–25
|
No
|
Anal swab
|
November 2014
|
1407
|
9 |
M |
21–25 |
No |
Anal swab |
November 2014 |
1407 |
Main Article
Page created: August 14, 2017
Page updated: August 14, 2017
Page reviewed: August 14, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.